Viking Therapeutics (VKTX) is identified by Oppenheimer among five potential biotech M&A candidates ahead of J.P. Morgan Healthcare Conference. Read more here.
This is an updated version of a story first published on Feb. 18, 2024. The original video can be viewed here. 2023 was the year the world learned to pronounce Cillian. The ancient Irish name ...